SPHERIQ Trademark

Trademark Overview

On Tuesday, December 12, 2023, a trademark application was filed for SPHERIQ with the United States Patent and Trademark Office. The USPTO has given the SPHERIQ trademark a serial number of 98310581. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, November 24, 2025. This trademark is owned by Sanofi. The SPHERIQ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical apparatus, namely, injection devices for pharmaceuticals; on-body injectors, namely, injection device for pharmaceuticals affixed to the body

Injection devices for pharmaceuticals sold filled with pharmaceutical preparations for the treatment of cancer, for use in oncology, and for the treatment of multiple myeloma; on-body injectors sold filled with pharmaceutical preparations for the treatment of cancer, for use in oncology, and for the treatment of multiple myeloma
spheriq

General Information

Serial Number98310581
Word MarkSPHERIQ
Filing DateTuesday, December 12, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, November 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements

Goods and ServicesMedical apparatus, namely, injection devices for pharmaceuticals; on-body injectors, namely, injection device for pharmaceuticals affixed to the body
Goods and ServicesInjection devices for pharmaceuticals sold filled with pharmaceutical preparations for the treatment of cancer, for use in oncology, and for the treatment of multiple myeloma; on-body injectors sold filled with pharmaceutical preparations for the treatment of cancer, for use in oncology, and for the treatment of multiple myeloma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, January 26, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75017
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75017
FR

Trademark Events

Event DateEvent Description
Friday, December 15, 2023NEW APPLICATION ENTERED
Friday, January 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 27, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, June 26, 2024ASSIGNED TO LIE
Wednesday, June 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 11, 2024ASSIGNED TO EXAMINER
Sunday, July 14, 2024NON-FINAL ACTION WRITTEN
Sunday, July 14, 2024NON-FINAL ACTION E-MAILED
Sunday, July 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 8, 2024FINAL REFUSAL WRITTEN
Sunday, September 8, 2024FINAL REFUSAL E-MAILED
Sunday, September 8, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 30, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 27, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, May 27, 2025SOU EXTENSION 1 FILED
Tuesday, May 27, 2025SOU EXTENSION 1 GRANTED
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 24, 2025SOU TEAS EXTENSION RECEIVED
Monday, November 24, 2025SOU EXTENSION 2 FILED
Monday, November 24, 2025SOU EXTENSION 2 GRANTED
Tuesday, November 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

spheriq treatment injection body pharmaceuticals sold filled pharmaceutical preparations oncology injectors